Blossomhill Therapeutics, Inc. (BLSM)
13.50
+1.15
(+9.31%)
USD |
NASDAQ |
Nov 06, 16:00
13.50
0.00 (0.00%)
After-Hours: 20:00
Blossomhill Therapeutics Market Cap : 429.10M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 429.10M |
| November 05, 2026 | 392.54M |
| November 04, 2026 | 393.50M |
| November 03, 2026 | 394.45M |
| November 02, 2026 | 394.77M |
| October 30, 2026 | 437.04M |
| October 29, 2026 | 483.45M |
| October 28, 2026 | 523.18M |
| October 27, 2026 | 500.77M |
| October 26, 2026 | 520.95M |
| October 23, 2026 | 465.01M |
| October 22, 2026 | 502.52M |
| October 21, 2026 | 495.84M |
| October 20, 2026 | 457.70M |
| October 19, 2026 | 450.07M |
| October 16, 2026 | 443.08M |
| October 15, 2026 | 476.14M |
| October 14, 2026 | 485.04M |
| October 13, 2026 | 492.03M |
| October 12, 2026 | 548.93M |
| October 09, 2026 | 555.60M |
| October 08, 2026 | 536.53M |
| October 07, 2026 | 527.95M |
| October 06, 2026 | 549.56M |
| October 05, 2026 | 633.79M |
| Date | Value |
|---|---|
| October 02, 2026 | 625.84M |
| October 01, 2026 | 590.88M |
| September 30, 2026 | 592.47M |
| September 29, 2026 | 679.24M |
| September 28, 2026 | 678.29M |
| September 25, 2026 | 627.75M |
| September 24, 2026 | 650.64M |
| September 23, 2026 | 710.07M |
| September 22, 2026 | 802.57M |
| September 21, 2026 | 851.84M |
| September 18, 2026 | 818.14M |
| September 17, 2026 | 852.47M |
| September 16, 2026 | 834.35M |
| September 15, 2026 | 704.67M |
| September 14, 2026 | 666.19M |
| September 11, 2026 | 639.23M |
| September 10, 2026 | 659.15M |
| September 09, 2026 | 674.16M |
| September 08, 2026 | 702.66M |
| September 04, 2026 | 674.47M |
| September 03, 2026 | 613.49M |
| September 02, 2026 | 593.87M |
| September 01, 2026 | 581.92M |
| August 31, 2026 | 560.78M |
| August 28, 2026 | 599.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IGC Pharma, Inc. | 20.48M |
| Cocrystal Pharma, Inc. | 14.34M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Arvinas, Inc. | 419.86M |
| Fulcrum Therapeutics, Inc. | 282.26M |
Market Cap Related Metrics
| Price | 13.50 |
| Earnings Yield | -15.96% |